Lithium Silicate Glass Ceramic And Glass With Divalent Metal Oxide
US-2017362118-A1 · Dec 21, 2017 · US
US10307342B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10307342-B2 |
| Application number | US-201515505411-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 21, 2015 |
| Priority date | Aug 22, 2014 |
| Publication date | Jun 4, 2019 |
| Grant date | Jun 4, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
There is provided an oral biofilm inhibitor having an exceptional inhibitory effect on oral biofilm formation. It is an oral biofilm inhibitor comprising a curable composition containing an antimicrobial agent, wherein a compressive strength of a cured product formed by curing the composition is 150 MPa or less, and a content of the antimicrobial agent is 0.001 to 3% by weight. An oral biofilm inhibitor thus obtained is used for inhibiting biofilm formation in an oral cavity by applying a curable composition containing an antimicrobial agent to a dental defect site for allowing the composition to cure at the dental defect site, and then disintegrating the cured composition.
Opening claim text (preview).
The invention claimed is: 1. An oral biofilm inhibitor consisting of a curable composition containing cetylpyridinium chloride in paste form and which is at least one of a hydraulic composition, a photocurable composition or a thermosetting composition, wherein a compressive strength of a cured product formed by curing the composition is 10 MPa or less, and a content of the cetylpyridinium chloride is 0.001 to 3% by weight. 2. The oral biofilm inhibitor according to claim 1 , used for inhibiting biofilm formation in an oral cavity by applying the curable composition containing the cetylpyridinium chloride to a dental defect site for allowing the composition to cure at the dental defect site, and then disintegrating the cured composition. 3. The oral biofilm inhibitor according to claim 2 , wherein the curable composition is again applied to the site where the cured composition has been disintegrated. 4. An oral biofilm inhibitor kit comprising a curable composition and cetylpyridinium chloride in paste form and which is at least one of a hydraulic composition, a photocurable composition or a thermosetting composition, wherein a compressive strength of a cured product formed by curing an oral biofilm inhibitor is 10 MPa or less, and the curable composition and the cetylpyridinium chloride are blended for use such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight. 5. An oral biofilm inhibitor kit comprising a curable composition in paste form which is at least one of a hydraulic composition, a photocurable composition or a thermosetting composition and a liquid agent containing water as a main component, wherein at least one of the curable composition and the liquid agent containing water as a main component comprises the cetylpyridinium chloride, a compressive strength of a cured product formed by curing the oral biofilm inhibitor is 10 MPa or less, and the curable composition and the liquid agent are blended for use such that a content of the cetylpyridinium chloride comes to be 0.001 to 3% by weight. 6. A method for producing an oral biofilm inhibitor comprising a curable composition containing cetylpyridinium chloride according to claim 1 , comprising blending the curable composition and the cetylpyridinium chloride such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight. 7. A method for producing an oral biofilm inhibitor comprising a curable composition containing cetylpyridinium chloride according to claim 2 , comprising blending the curable composition and the cetylpyridinium chloride such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight. 8. A method for producing an oral biofilm inhibitor comprising a curable composition containing cetylpyridinium chloride according to claim 3 , comprising blending the curable composition and the cetylpyridinium chloride such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight.
Antibacterial agents · CPC title
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title
Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish · CPC title
comprising natural or synthetic resins · CPC title
Preparations for artificial teeth, for filling teeth or for capping teeth · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.